ILARIS: payments to doctors
Payments that named ILARIS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.2M
- Providers
- 2,550
- Transactions
- 7,151
- Average per transaction
- $166
The per-transaction average — $166 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,550 providers the average total is $466, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis | $1,107,803 | 93.3% |
| Novartis Pharma AG | $79,749 | 6.7% |